Compare Quest Diagnostics Inc (DGX) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Strategy Inc. — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Strategy Inc. trades at $97.35 (market cap $37.84B). The key difference: Strategy Inc. is the larger of the two by market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Strategy Inc. pays none. Which is the better fit depends on your goals.
| DGX | MSTR | |
|---|---|---|
Market Cap | $26.21B | $37.84B |
Sector | Health | Technology |
52-Week High | $238.50 | $394.39 |
52-Week Low | $173.49 | $82.31 |
Enterprise Value | $31.97B | $56.61B |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
